Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 2
2005 3
2006 3
2007 3
2008 3
2009 2
2010 6
2011 2
2012 2
2013 2
2014 5
2015 5
2016 8
2017 13
2018 16
2019 12
2020 15
2021 31
2022 16
2023 26
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Editorial Comment.
Hugar LA, Gilbert SM, Li R. Hugar LA, et al. Among authors: li r. J Urol. 2022 Sep;208(3):578. doi: 10.1097/JU.0000000000002748.01. Epub 2022 Sep 1. J Urol. 2022. PMID: 35942791 No abstract available.
TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures.
Chaurio RA, Anadon CM, Lee Costich T, Payne KK, Biswas S, Harro CM, Moran C, Ortiz AC, Cortina C, Rigolizzo KE, Sprenger KB, Mine JA, Innamarato P, Mandal G, Powers JJ, Martin A, Wang Z, Mehta S, Perez BA, Li R, Robinson J, Kroeger JL, Curiel TJ, Yu X, Rodriguez PC, Conejo-Garcia JR. Chaurio RA, et al. Among authors: li r. Immunity. 2022 Jan 11;55(1):115-128.e9. doi: 10.1016/j.immuni.2021.12.007. Immunity. 2022. PMID: 35021053 Free PMC article.
Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers.
Biswas S, Mandal G, Anadon CM, Chaurio RA, Lopez-Bailon LU, Nagy MZ, Mine JA, Hänggi K, Sprenger KB, Innamarato P, Harro CM, Powers JJ, Johnson J, Fang B, Eysha M, Nan X, Li R, Perez BA, Curiel TJ, Yu X, Rodriguez PC, Conejo-Garcia JR. Biswas S, et al. Among authors: li r. Immunity. 2023 Nov 14;56(11):2570-2583.e6. doi: 10.1016/j.immuni.2023.09.013. Epub 2023 Oct 30. Immunity. 2023. PMID: 37909039 Free article.
Editorial Comment.
Li R, Gilbert SM. Li R, et al. J Urol. 2022 Feb;207(2):312-313. doi: 10.1097/JU.0000000000002242.01. Epub 2021 Nov 8. J Urol. 2022. PMID: 34994655 No abstract available.
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group.
Tan WS, Steinberg G, Witjes JA, Li R, Shariat SF, Roupret M, Babjuk M, Bivalacqua TJ, Psutka SP, Williams SB, Cookson MS, Palou J, Kamat AM. Tan WS, et al. Among authors: li r. Eur Urol Oncol. 2022 Oct;5(5):505-516. doi: 10.1016/j.euo.2022.05.005. Epub 2022 Jun 17. Eur Urol Oncol. 2022. PMID: 35718695 Review.
Editorial Comment.
Li R. Li R. J Urol. 2021 Sep;206(3):567. doi: 10.1097/JU.0000000000001834.01. Epub 2021 Jun 14. J Urol. 2021. PMID: 34121428 No abstract available.
Editorial Comment.
Davaro F, Davaro E, Li R. Davaro F, et al. Among authors: li r. J Urol. 2024 Feb;211(2):253. doi: 10.1097/JU.0000000000003778.03. Epub 2024 Feb 1. J Urol. 2024. PMID: 38193408 No abstract available.
Reply by Authors.
Matulay JT, Li R, Hensley PJ, Brooks NA, Narayan VM, Grossman HB, Navai N, Dinney CPN, Kamat AM. Matulay JT, et al. Among authors: li r. J Urol. 2021 Jun;205(6):1620-1621. doi: 10.1097/JU.0000000000001633.03. Epub 2021 Mar 18. J Urol. 2021. PMID: 33734859 No abstract available.
Reply By Authors.
Hajiran A, Azizi M, Aydin AM, Zemp L, Peyton CC, Dhillon J, Nealon S, Reich RR, Cao B, Li R, Manley BJ, Sexton WJ, Gilbert SM. Hajiran A, et al. Among authors: li r. J Urol. 2021 Jan;205(1):108. doi: 10.1097/JU.0000000000001325.03. Epub 2020 Oct 23. J Urol. 2021. PMID: 33095102 No abstract available.
162 results